Skip to main content
. 2015 Jun 4;2(2):119–130. doi: 10.3233/JND-150081

Table 1.

Effect of VPA on SMN mRNA levels in the VALIANT Trial

Group 1 (VPA/Placebo) Group 2 (Placebo/VPA) Treatment effect
V4 V6 V4 V6 p value
FL-SMN mRNA (mol/ng) 405.2 (218.3) 433.9 (195.5) 343.3 (103.9) 424.2 (256.2) 0.790
N 13 13 16 16
SMNΔ7 mRNA (mol/ng) 186.3 (112.1) 194.5 (86.6) 153.8 (72.0) 154.9 (100.1) 0.268
N 13 13 18 18